NovaBone receives FDA approval for MIS system: 5 things to know

NovaBone received FDA approval for the NovaBone MacroFORM MIS Delivery System designed for minimally invasive orthopedic procedures.

Advertisement

Here are five things to know:

 

1. The system was developed for surgeons requiring controlled and precise delivery of bone grafting material to surgical sites that aren’t readily accessible.

 

2. The system allows surgeons to deliver bone marrow aspirate to a graft housed in a closed, ready to use minimally invasive cannula.

 

3. NovaBone released six new collagen products in the last 12 months based on the company’s regenerative medicine technology and core competencies in designing innovative and cost-effective medical devices.

 

4. NovaBone’s MacroFORM technology offers bioactivity and is available in multiple formulations and delivery options.

 

5. NovaBone is a privately-held company based in Florida.

 

More articles on orthopedic devices:
ECM Medcial to distribute Vertebral Technologies’ Interfuse System in China
MIS SI joint fusion: Are outcomes positive? 10 things to know on 3 new studies
Amedica releases lumbar interbody spinal fusion device

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.